REFRESH RELIEVA PF- carboxymethylcellulose sodium and glycerin solution/ drops 
Allergan, Inc.

----------

REFRESH® RELIEVA™ PF (Unit Dose)
Lubricant Eye Drops
Drug Facts

Active ingredients

Carboxymethylcellulose sodium 0.5%

Glycerin 1.0%

Purpose

Eye lubricant

Eye lubricant

Uses

Warnings

Stop use and ask a doctor if

you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

To open, TWIST AND PULL TAB TO REMOVE.

Other information

Inactive ingredients

Calcium chloride dihydrate; erythritol; levocarnitine; magnesium chloride hexahydrate; potassium chloride; purified water; sodium lactate; and sodium hyaluronate. May contain hydrochloric acid and/or sodium hydroxide (to adjust pH).

Questions or comments?

Refreshbrand.com

PRINCIPAL DISPLAY PANEL

Refresh®
RELIEVA™ PF
Lubricates and Protects
Recommended for

Sensitive Eyes
PRESERVATIVE-FREE
30 Vials 0.01 fl oz (0.4 mL) Sterile

Refresh®
RELIEVA™ PF
Lubricates and Protects
Recommended for
Sensitive Eyes
PRESERVATIVE-FREE
30 Vials 0.01 fl oz (0.4 mL) Sterile

PRINCIPAL DISPLAY PANEL

Refresh®
RELIEVA™ PF
Lubricates and Protects
Recommended for Sensitive Eyes
5 Vials 0.01 fl oz (0.4 mL) Sterile

Refresh®
RELIEVA™ PF
Lubricates and Protects
Recommended for Sensitive Eyes
5 Vials 0.01 fl oz (0.4 mL) Sterile

REFRESH RELIEVA PF 
carboxymethylcellulose sodium and glycerin solution/ drops
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0023-4515
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CARBOXYMETHYLCELLULOSE SODIUM (UNII: K679OBS311) (CARBOXYMETHYLCELLULOSE - UNII:05JZI7B19X) CARBOXYMETHYLCELLULOSE SODIUM5 mg  in 1 mL
GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) GLYCERIN10 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
CALCIUM CHLORIDE (UNII: M4I0D6VV5M)  
ERYTHRITOL (UNII: RA96B954X6)  
LEVOCARNITINE (UNII: 0G389FZZ9M)  
MAGNESIUM CHLORIDE (UNII: 02F3473H9O)  
POTASSIUM CHLORIDE (UNII: 660YQ98I10)  
WATER (UNII: 059QF0KO0R)  
SODIUM LACTATE (UNII: TU7HW0W0QT)  
HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
HYDROCHLORIC ACID (UNII: QTT17582CB)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0023-4515-3030 in 1 CARTON09/25/2020
10.4 mL in 1 VIAL, SINGLE-USE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01809/25/2020
REFRESH RELIEVA PF 
carboxymethylcellulose sodium and glycerin solution/ drops
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0023-9537
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CARBOXYMETHYLCELLULOSE SODIUM (UNII: K679OBS311) (CARBOXYMETHYLCELLULOSE - UNII:05JZI7B19X) CARBOXYMETHYLCELLULOSE SODIUM5 mg  in 1 mL
GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) GLYCERIN10 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
CALCIUM CHLORIDE (UNII: M4I0D6VV5M)  
ERYTHRITOL (UNII: RA96B954X6)  
LEVOCARNITINE (UNII: 0G389FZZ9M)  
MAGNESIUM CHLORIDE (UNII: 02F3473H9O)  
POTASSIUM CHLORIDE (UNII: 660YQ98I10)  
WATER (UNII: 059QF0KO0R)  
SODIUM LACTATE (UNII: TU7HW0W0QT)  
HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
HYDROCHLORIC ACID (UNII: QTT17582CB)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0023-9537-055 in 1 CARTON09/25/2020
10.4 mL in 1 VIAL, SINGLE-USE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01809/25/2020
Labeler - Allergan, Inc. (144796497)

Revised: 6/2022
Document Id: 9f04116b-954c-46e0-b755-d6273db959cd
Set id: d5d3df4a-a311-4f2d-9a24-edfec1a6c9f9
Version: 5
Effective Time: 20220624
 
Allergan, Inc.